Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Mouse models of adrenocortical tumors.

Basham KJ, Hung HA, Lerario AM, Hammer GD.

Mol Cell Endocrinol. 2016 Feb 5;421:82-97. doi: 10.1016/j.mce.2015.11.031. Epub 2015 Dec 8.

PMID:
26678830
2.

GATA factors in endocrine neoplasia.

Pihlajoki M, Färkkilä A, Soini T, Heikinheimo M, Wilson DB.

Mol Cell Endocrinol. 2016 Feb 5;421:2-17. doi: 10.1016/j.mce.2015.05.027. Epub 2015 May 28. Review.

PMID:
26027919
3.

Adrenocortical zonation, renewal, and remodeling.

Pihlajoki M, Dörner J, Cochran RS, Heikinheimo M, Wilson DB.

Front Endocrinol (Lausanne). 2015 Mar 5;6:27. doi: 10.3389/fendo.2015.00027. eCollection 2015. Review.

4.

A Novel Population of Inner Cortical Cells in the Adrenal Gland That Displays Sexually Dimorphic Expression of Thyroid Hormone Receptor-β1.

Huang CC, Kraft C, Moy N, Ng L, Forrest D.

Endocrinology. 2015 Jun;156(6):2338-48. doi: 10.1210/en.2015-1118. Epub 2015 Mar 16.

PMID:
25774556
5.

Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue.

Röhrig T, Pihlajoki M, Ziegler R, Cochran RS, Schrade A, Schillebeeckx M, Mitra RD, Heikinheimo M, Wilson DB.

Mol Cell Endocrinol. 2015 Jun 15;408:165-77. doi: 10.1016/j.mce.2014.12.003. Epub 2014 Dec 8. Review.

PMID:
25498963
6.

Regulation of the adrenocortical stem cell niche: implications for disease.

Walczak EM, Hammer GD.

Nat Rev Endocrinol. 2015 Jan;11(1):14-28. doi: 10.1038/nrendo.2014.166. Epub 2014 Oct 7. Review.

7.

Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation.

Hofland J, Steenbergen J, Voorsluijs JM, Verbiest MM, de Krijger RR, Hofland LJ, de Herder WW, Uitterlinden AG, Feelders RA, de Jong FH.

PLoS One. 2014 Aug 11;9(8):e104944. doi: 10.1371/journal.pone.0104944. eCollection 2014.

8.

Inhibin at 90: from discovery to clinical application, a historical review.

Makanji Y, Zhu J, Mishra R, Holmquist C, Wong WP, Schwartz NB, Mayo KE, Woodruff TK.

Endocr Rev. 2014 Oct;35(5):747-94. doi: 10.1210/er.2014-1003. Epub 2014 Jul 22. Review.

9.

mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD).

de Joussineau C, Sahut-Barnola I, Tissier F, Dumontet T, Drelon C, Batisse-Lignier M, Tauveron I, Pointud JC, Lefrançois-Martinez AM, Stratakis CA, Bertherat J, Val P, Martinez A.

Hum Mol Genet. 2014 Oct 15;23(20):5418-28. doi: 10.1093/hmg/ddu265. Epub 2014 May 27.

10.

Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells.

Freedman BD, Kempna PB, Carlone DL, Shah MS, Guagliardo NA, Barrett PQ, Gomez-Sanchez CE, Majzoub JA, Breault DT.

Dev Cell. 2013 Sep 30;26(6):666-73. doi: 10.1016/j.devcel.2013.07.016. Epub 2013 Sep 12.

11.

Conditional mutagenesis of Gata6 in SF1-positive cells causes gonadal-like differentiation in the adrenal cortex of mice.

Pihlajoki M, Gretzinger E, Cochran R, Kyrönlahti A, Schrade A, Hiller T, Sullivan L, Shoykhet M, Schoeller EL, Brooks MD, Heikinheimo M, Wilson DB.

Endocrinology. 2013 May;154(5):1754-67. doi: 10.1210/en.2012-1892. Epub 2013 Mar 7.

12.

Aged PROP1 deficient dwarf mice maintain ACTH production.

Nasonkin IO, Ward RD, Bavers DL, Beuschlein F, Mortensen AH, Keegan CE, Hammer GD, Camper SA.

PLoS One. 2011;6(12):e28355. doi: 10.1371/journal.pone.0028355. Epub 2011 Dec 1.

13.

Animal models of adrenocortical tumorigenesis.

Beuschlein F, Galac S, Wilson DB.

Mol Cell Endocrinol. 2012 Mar 31;351(1):78-86. doi: 10.1016/j.mce.2011.09.045. Epub 2011 Nov 11.

14.

The cAMP pathway and the control of adrenocortical development and growth.

de Joussineau C, Sahut-Barnola I, Levy I, Saloustros E, Val P, Stratakis CA, Martinez A.

Mol Cell Endocrinol. 2012 Mar 31;351(1):28-36. doi: 10.1016/j.mce.2011.10.006. Epub 2011 Oct 15. Review.

15.

Adrenocortical stem and progenitor cells: unifying model of two proposed origins.

Wood MA, Hammer GD.

Mol Cell Endocrinol. 2011 Apr 10;336(1-2):206-12. doi: 10.1016/j.mce.2010.11.012. Epub 2010 Nov 20. Review.

16.

Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice.

Sahut-Barnola I, de Joussineau C, Val P, Lambert-Langlais S, Damon C, Lefrançois-Martinez AM, Pointud JC, Marceau G, Sapin V, Tissier F, Ragazzon B, Bertherat J, Kirschner LS, Stratakis CA, Martinez A.

PLoS Genet. 2010 Jun 10;6(6):e1000980. doi: 10.1371/journal.pgen.1000980.

17.

Concomitant mutations in the P450 oxidoreductase and androgen receptor genes presenting with 46,XY disordered sex development and androgenization at adrenarche.

Idkowiak J, Malunowicz EM, Dhir V, Reisch N, Szarras-Czapnik M, Holmes DM, Shackleton CH, Davies JD, Hughes IA, Krone N, Arlt W.

J Clin Endocrinol Metab. 2010 Jul;95(7):3418-27. doi: 10.1210/jc.2010-0058. Epub 2010 Apr 21.

18.

Inhibin-A antagonizes TGFbeta2 signaling by down-regulating cell surface expression of the TGFbeta coreceptor betaglycan.

Looyenga BD, Wiater E, Vale W, Hammer GD.

Mol Endocrinol. 2010 Mar;24(3):608-20. doi: 10.1210/me.2008-0374. Epub 2010 Feb 16.

19.

In search of adrenocortical stem and progenitor cells.

Kim AC, Barlaskar FM, Heaton JH, Else T, Kelly VR, Krill KT, Scheys JO, Simon DP, Trovato A, Yang WH, Hammer GD.

Endocr Rev. 2009 May;30(3):241-63. doi: 10.1210/er.2008-0039. Epub 2009 Apr 29. Review.

20.

Review paper: origin and molecular pathology of adrenocortical neoplasms.

Bielinska M, Parviainen H, Kiiveri S, Heikinheimo M, Wilson DB.

Vet Pathol. 2009 Mar;46(2):194-210. doi: 10.1354/vp.46-2-194. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk